<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500069</url>
  </required_header>
  <id_info>
    <org_study_id>METC-14-3-006</org_study_id>
    <nct_id>NCT02500069</nct_id>
  </id_info>
  <brief_title>Location Specific Differences in Intestinal Brake Activation</brief_title>
  <official_title>The Effect of Intestinal Brake Activation at Different Locations in the Gut on Food Intake and Hormone Release</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The appearance of intact macronutrients in the small intestine can result in the activation
      of an intestinal brake; a negative feedback mechanism from different parts of the intestine
      to the stomach, the small intestine and to the central nervous system. These processes
      inhibit food processing, appetite sensations and food intake, and furthermore they increase
      feelings of satiety and satiation. The researchers will investigate the effects of
      intraduodenal, intrajejunal and intralileal infusion of casein (protein) on ad libitum food
      intake, satiation and in vivo release of the gut satiety peptides CCK, PYY and GLP-1 and
      glucose and insulin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure ad libitum food intake at the end of the test day</measure>
    <time_frame>1 test day</time_frame>
    <description>Food intake measurement in kcal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS scores for hunger and satiety</measure>
    <time_frame>1 test day</time_frame>
    <description>Visual analogue scale for hunger and satiety in mm (0-100 mm scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI peptides</measure>
    <time_frame>1 test day</time_frame>
    <description>Measurement of GI peptide release during protein infusion (CCK, GLP-1, PYY, insulin and glucose)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Ileal Brake</condition>
  <condition>Satiety</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <condition>Overeating</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tap water infusion in all three locations (duodenum, jejunum and ileum)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duodenum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in duodenum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jejunum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in jejunum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ileum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of casein in ileum</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>infusion of tap water in all regions (duodenum, jejunum and ileum)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in duodenum)</intervention_name>
    <description>infusion of protein in duodenum</description>
    <arm_group_label>Duodenum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in jejunum)</intervention_name>
    <description>infusion of protein in jejunum</description>
    <arm_group_label>Jejunum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Casein (in ileum)</intervention_name>
    <description>infusion of protein in ileum</description>
    <arm_group_label>Ileum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

        In order to be eligible to participate in this study, a subject must meet all of the
        following criteria:

          -  Based on medical history and previous examination, no gastrointestinal complaints can
             be defined.

          -  Age between 18 and 65 years. This study will include healthy adult subjects (male and
             female). Women must be taking contraceptives.

          -  BMI between 18 and 25 kg/m2)

          -  Weight stable over at least the last 6 months (â‰¤5% weight change)

        Exclusion criteria

        A potential subject who meets any of the following criteria will be excluded from
        participation in this study:

          -  History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic,
             hematological/immunologic, HEENT (head, ears, eyes, nose, throat),
             dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine,
             neurological/psychiatric diseases, allergy, major surgery and/or laboratory
             assessments which might limit participation in or completion of the study protocol.
             The severity of the disease (major interference with the execution of the experiment
             or potential influence on the study outcomes) will be decided by the principal
             investigator.

          -  Use of medication, including vitamin supplementation, except oral contraceptives,
             within 14 days prior to testing

          -  Administration of investigational drugs or participation in any scientific
             intervention study which may interfere with this study (to be decided by the principle
             investigator), in the 180 days prior to the study

          -  Major abdominal surgery interfering with gastrointestinal function (uncomplicated
             appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon
             judgement of the principle investigator)

          -  Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological
             dynamic)

          -  Pregnancy, lactation

          -  Excessive alcohol consumption (&gt;20 alcoholic consumptions per week)

          -  Smoking

          -  Blood donation within 3 months before the study period

          -  Self-admitted HIV-positive state

          -  Weight &lt;60kg

          -  Evidence of casein or sucrose hypersensitivity

          -  Participation in any other study in which radiation was used, within 12 months before
             the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A Masclee, Prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6003</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>July 14, 2015</last_update_submitted>
  <last_update_submitted_qc>July 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

